Table 1.

The chromosomal location of HCP5 and the ERV16 (LTR16B and ERV3-16A3) retroelement between the pseudogene HLA-X and the HCG26 lncRNA gene within the HLA class I region [30].

Sequence Name	Location on Chr6 *	Length bp	Orient.	Feature
MERC21	31,461,669–31,462,057	389	+	LTR fragment
HLA-X	31,461,846–31,462,490	645	+	Silent pseudogene
MERC21	31,462,544–31,462,625	82	+	LTR fragment
HLA-UTR	31,462,625–31,463,419	794	+	HLA-5′UTR + exon 1
HCP5-5′ncr	31,462,464–31,463,413	950	+	HLA class I promoter homologs
DNase region	31,463,001–31,463,190	190	+	100% reliability score
HCP5	31,463,180–31,465,809	2630	+	lncRNA gene
3′LTR16B	31,463,420–31,463,715	296	−	3′LTR (nt 150–446 in HCP5 RNA)
ERV3-16A3	31,463,716–31,464,933	1218	−	Internal (nt 447–2547 in HCP5 RNA)
AluSp	31,465,920–31,466,225	306	−	Insertion within ERV3-16A3
ERV3-16A3	31,466,237–31,467,707	1471	−	Internal
THE1B	31,467,708–31,468,050	343	+	Fragmented insertion within ERV3-16A3
ERV3-16A3	31,468,051–31,468,201	151	−	Internal
ERV3-16A3	31,468,362–31,468,644	283	−	Internal
5′LTR16B2	31,468,881–31,469,043	163	−	5′LTR
AluSx	31,469,044–31,469,282	239	−	Insertion within LTR16B
5′LTR16B2	31,469,283–31,469,592	310	−	5′LTR
L2	31,469,593–31,470,361	769	−	L2 LINE
MLT1E2	31,470,734–31,471,317	584	−	ERL-MaLR, LTR fragment
L2	31,471,325–31,472,047	723	−	L2 LINE
HCG26	31,471,229–31,472,408	1180	+	LncRNA

* Chr6:31461669-31472408, GRCh38.p12 assembly (annotation release 109 in March 2018). 5′ncr is 5′ noncoding region. Orientation of the sequence is on the +ve DNA strand or the −ve (complementary) DNA strand.